NXS — Next Science Balance Sheet
0.000.00%
Last trade - 00:00- AU$99.18m
- AU$86.42m
- $22.18m
- 31
- 22
- 63
- 35
Annual balance sheet for Next Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 16.9 | 15.3 | 7.37 | 5.11 | 9.28 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.64 | 3.39 | 0.887 | 1.74 | 3.59 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 19.3 | 20.3 | 10.2 | 8.26 | 14 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.21 | 1.02 | 0.916 | 1.75 | 1.52 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 22.7 | 23.6 | 13.7 | 12.5 | 17.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.72 | 3.23 | 1.54 | 2.61 | 3.84 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.34 | 4.73 | 2.95 | 4.42 | 5.08 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 19.4 | 18.9 | 10.8 | 8.04 | 12.8 |
| Total Liabilities & Shareholders' Equity | 22.7 | 23.6 | 13.7 | 12.5 | 17.9 |
| Total Common Shares Outstanding |